Saba Capital Acquires Stake in Gabelli Healthcare Trust
Saba Capital Management has purchased $4,940 worth of shares in the Gabelli Healthcare & WellnessRx Trust.
Saba Capital Management, the New York-based closed-end fund activist investor, has acquired a $4,940 position in the Gabelli Healthcare & WellnessRx Trust, according to a regulatory disclosure. The purchase adds another healthcare-focused closed-end fund to Saba's growing portfolio of targeted positions.
Saba Capital, led by founder Boaz Weinstein, has built a reputation for taking stakes in closed-end funds that trade at discounts to their net asset value, often pushing for shareholder-friendly measures such as tender offers or fund liquidations. The Gabelli Healthcare & WellnessRx Trust focuses on equities in the healthcare and pharmaceutical sectors.
Read more Wells Fargo Lifts CBOE Holdings Price Target to $357 →
The relatively modest dollar amount of the disclosed transaction may reflect an initial or incremental position, a common strategy among activist investors who establish early footholds before potentially increasing their stakes. Gabelli Funds, the trust's manager, is a well-known name in the closed-end fund space with a broad lineup of sector-specific vehicles.
Investors in closed-end funds have increasingly faced pressure from activists like Saba, which has argued that persistent discounts to net asset value represent a failure of fund governance. The healthcare sector's defensive characteristics have made it a recurring area of interest for income-oriented closed-end fund strategies.
Continue reading at All News.
